Anzeige
Mehr »
Login
Samstag, 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40A3X | ISIN: US98585K8541 | Ticker-Symbol: N/A
Frankfurt
02.05.24
08:31 Uhr
0,184 Euro
0,000
0,00 %
1-Jahres-Chart
YIELD10 BIOSCIENCE INC Chart 1 Jahr
5-Tage-Chart
YIELD10 BIOSCIENCE INC 5-Tage-Chart
GlobeNewswire (Europe)
192 Leser
Artikel bewerten:
(1)

Delisting of Securities of CONX Corp.; Priveterra Acquisition Corp. II; Yield10 Bioscience, Inc.; Aesthetic Medical International Holdings Group; Breeze Holdings Acquisition Corp.; Quadro Acquisition One Corp.; DermTech, Inc.; TRACON Pharmaceuticals ...

Finanznachrichten News

NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, units, and warrants of CONX Corp. CONX Corp.'s securities were suspended on May 6, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, units, and warrants of Priveterra Acquisition Corp. II. Priveterra Acquisition Corp. II's securities were suspended on May 10, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Yield10 Bioscience, Inc. Yield10 Bioscience, Inc.'s securities were suspended on May 16, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the American Depositary Shares of Aesthetic Medical International Holdings Group Ltd. Aesthetic Medical International Holdings Group Ltd.'s securities were suspended on May 21, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, rights, and warrants of Breeze Holdings Acquisition Corp. Breeze Holdings Acquisition Corp.'s securities were suspended on May 29, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares, units, and warrants of Quadro Acquisition One Corp. Quadro Acquisition One Corp.'s securities were suspended on May 29, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of DermTech, Inc. DermTech, Inc.'s securities were suspended on June 27, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of TRACON Pharmaceuticals, Inc. TRACON Pharmaceuticals, Inc.'s securities were suspended on June 28, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common and warrants of eFFECTOR Therapeutics, Inc. eFFECTOR Therapeutics, Inc.'s securities were suspended on July 3, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Dynatronics Corporation. Dynatronics Corporation's securities were suspended on July 9, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock, warrants, and units of Canna-Global Acquisition Corp. Canna-Global Acquisition Corp.'s securities were suspended on July 9, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2024 GlobeNewswire (Europe)
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.